Gainers
PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares jumped 43.4% to close at $3.27. PharmaCyte Biotech recently reported closing of $15-million public offering.
Eargo (NASDAQ:EAR) reported quarterly losses of $(0.36) per share which missed the analyst consensus estimate of $(0.26) by 38.46 percent. The company reported quarterly sales of $22.90 million which beat the analyst